Data / Drug companies / Sterling Pharma Solutions Limited
Sterling Pharma Solutions Limited: 43 products in the FDA NDC directory, labeler code 50384
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Sterling Pharma Solutions Limited (labeler code 50384) lists 43 products in the FDA National Drug Code Directory. By type: 42 bulk ingredients, 1 drugs for further processing. Its main marketing category is bulk ingredients. The newest product started marketing on July 24, 2026.
The request: Watch Sterling Pharma Solutions Limited (FDA labeler code 50384): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 50384
- Products in commercial distribution
- 43
- Packages
- 43
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Controlled substance products
- Schedule II 1
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- March 25, 1994
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Bulk ingredients | 40 | 93% |
| Bulk ingredients for compounding | 2 | 4.7% |
| Drugs for further processing | 1 | 2.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Bulk ingredients | 42 | 97.7% |
| Drugs for further processing | 1 | 2.3% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Powder | 39 | 90.7% |
| Suspension | 1 | 2.3% |
| Injection | 1 | 2.3% |
| Injection, solution | 1 | 2.3% |
| Liquid | 1 | 2.3% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Centanafadine hcl | 50384-0401 | Powder | Bulk ingredients | July 24, 2026 |
| Avatrombopag maleate | 50384-0399 | Powder | Bulk ingredients | June 9, 2025 |
| Isoproterenol hydrochloride | 50384-0363 | Powder | Bulk ingredients | June 9, 2025 |
| Taurolidine | 50384-0235 | Powder | Bulk ingredients | November 15, 2023 |
| Nilotinib hydrochloride | 50384-6700 | Powder | Bulk ingredients | July 3, 2023 |
| Dabrafenib mesylate | 50384-6600 | Powder | Bulk ingredients | July 3, 2023 |
| Capmatinib hydrochloride | 50384-6500 | Powder | Bulk ingredients | July 3, 2023 |
| Octreotide acetate | 50384-6400 | Powder | Bulk ingredients | July 3, 2023 |
| Ciclosporin | 50384-6300 | Powder | Bulk ingredients | July 3, 2023 |
| Imatinib mesylate | 50384-6200 | Powder | Bulk ingredients | July 3, 2023 |
| Valsartan | 50384-6100 | Powder | Bulk ingredients | July 3, 2023 |
| Avatrombopag maleate | 50384-0340 | Powder | Bulk ingredients | December 6, 2022 |
| Fuzapladib sodium | 50384-0287 | Powder | Bulk ingredients | November 14, 2022 |
| Methylenediphosphonic acid | 50384-0425 | Injection | Bulk ingredients | November 13, 2020 |
| Oliceridine fumarate | 50384-0707 | Injection, solution | Bulk ingredients | August 6, 2020 |
| Tazemetostat hydrobromide | 50384-4000 | Powder | Bulk ingredients | January 23, 2020 |
| Diroximel fumarate | 50384-5015 | Powder | Bulk ingredients | October 30, 2019 |
| Pexidartinib hcl | 50384-0750 | Powder | Bulk ingredients for compounding | August 5, 2019 |
| Ferric maltol | 50384-5100 | Powder | Bulk ingredients | July 1, 2019 |
| Sodium thiosulfate pentahydrate | 50384-0330 | Powder | Bulk ingredients for compounding | May 1, 2019 |
| Tetrakis(2-methoxyisobutylisocyanide)copper(i) tetrafluoroborate | 50384-2804 | Powder | Bulk ingredients | January 1, 2017 |
| Deoxycholic acid | 50384-0151 | Powder | Bulk ingredients | April 29, 2015 |
| Grapiprant | 50384-0500 | Powder | Bulk ingredients | January 1, 2015 |
| Ractopamine hydrochloride | 50384-5060 | Suspension | Drugs for further processing | July 16, 2013 |
| Tetrakis(2-methoxy isobutyl isonitrile) copper(i) tetrafluoroborate | 50384-0700 | Powder | Bulk ingredients | July 10, 2009 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.